You are here: Industry Insights > cancer

News List

Takeda, Tesaro ink strategic deal to co-develop and commercialize cancer drug biospectrumasia
August 02, 2017
The deal, worth $340 mn gives Takeda exclusive commercial rights for all potential future niraparib indications in Japan
MSD’s Keytruda backed for bladder cancer pharmatimes
July 26, 2017
European regulators have backed expanding approval of MSD’s immunotherapy Keytruda to include the treatment of locally advanced or metastatic urothelial carcinoma, a type of bladder cancer.
Takeda’s lung cancer drug approved in the US pharmatimes
May 03, 2017
Takeda Pharmaceuticals has bagged approval for Alunbrig in the US as a treatment for a specific group of lung cancer patients.
Research identifies marker for aggressive ovarian cancer pharmafile
April 27, 2017
Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and...
Quarter of cancer patients visit GP three times with no diagnosis pharmafile
April 26, 2017
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from ...
BMS, Transgene to test new lung cancer combination therapy pharmatimes
April 26, 2017
Bristol-Myers Squibb and Transgene are to test a potential new therapy for advanced non-squamous non-small cell lung cancer (NSCLC)...
Investigational ImmunoGen drug gives hope against platinum-resistant ovarian cancer pharmafile
April 21, 2017
Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective...
Genentech's Tecentriq receives FDA-accelerated approval for advanced bladder cancer treatment pharmaceutical-technology
April 19, 2017
Roche Group member Genentech has received accelerated approval from the US Food and Drug Administration (FDA) for Tecentriq...
Austrian scientists modify and reinforce host defence peptide from breast milk to detect cancer cell pharmaceutical-technology
April 12, 2017
Scientists at the University of Graz in Austria have modified and reinforced a host defence peptide from breast milk to...
Roche's lung cancer c beats Pfizer rival in study pharmafile
April 11, 2017
Roche has announced that its drug Alecensa (alectinib) succeeded in meeting its primary endpoint in a Phase 3 trial ...

Previous page 1 2 3 4 Next page